9Q34 LOSS OF HETEROZYGOSITY IN A TUBEROUS SCLEROSIS ASTROCYTOMA SUGGESTS A GROWTH SUPPRESSOR-LIKE ACTIVITY ALSO FOR THE TSC1 GENE

被引:119
作者
CARBONARA, C
LONGA, L
GROSSO, E
BORRONE, C
GARRE, MG
BRISIGOTTI, M
MIGONE, N
机构
[1] UNIV TURIN, CNR, CTR IMMUNOGENET & ONCOL SPERIMENTALE, I-10126 TURIN, ITALY
[2] UNIV TURIN, DIPARTIMENTO GENET BIOL & CHIM MED, I-10126 TURIN, ITALY
[3] IST GIANNINA GASLINI, DIV EMATOONCOL PEDIAT, I-16148 GENOA, ITALY
[4] OSPED CIVILE, DIV ANAT PATOL, I-25100 BRESCIA, ITALY
关键词
D O I
10.1093/hmg/3.10.1829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tuberous sclerosis is an autosomal dominant disease whose characteristic feature is the development of multiple hamartomas in a variety of organs and tissues. Two major loci have been identified so far: TSC1 on chromosome 9q34 and TSC2 on chromosome 16p13.3. Loss of heterozygosity at 16p13.3-associated markers has been recently observed in hamartomatous lesions of some tuberous sclerosis patients. Here we report the first evidence of loss of heterozygosity at the TSC1 critical region in a giant cell astrocytoma of a familial tuberous sclerosis case. Segregation analysis showed that the 9q34 haplotype lost carried the putative normal TSC1 gene. These data support the hypothesis of both a germline and somatic loss-of-function mutation for the development of tuberous sclerosis hamartomas and suggest a tumor-suppressor-like activity also for the TSC1 gene product. Finally, the possible significance of a second small region of loss of heterozygosity at 9p21, found in the same astrocytoma, is discussed.
引用
收藏
页码:1829 / 1832
页数:4
相关论文
共 37 条
  • [1] BURLEY MW, 1993, CYTOGENET CELL GENET, V64, P109
  • [2] CHENG JQ, 1993, CANCER RES, V53, P4761
  • [3] HOMOZYGOUS DELETION OF THE ALPHA-INTERFERON AND BETA-1-INTERFERON GENES IN HUMAN-LEUKEMIA AND DERIVED CELL-LINES
    DIAZ, MO
    ZIEMIN, S
    LEBEAU, MM
    PITHA, P
    SMITH, SD
    CHILCOTE, RR
    ROWLEY, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) : 5259 - 5263
  • [4] FOUGEROUSSE F, 1992, NUCLEIC ACIDS RES, V20, P1165, DOI 10.1093/nar/20.5.1165-a
  • [5] FRYER AE, 1987, LANCET, V1, P659
  • [6] 3 DINUCLEOTIDE REPEAT POLYMORPHISMS ON CHROMOSOME-9 (D9S200, D9S201, D9S199)
    GRAW, SL
    KWIATKOWSKI, DJ
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (05) : 614 - 614
  • [7] LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS
    GREEN, AJ
    SMITH, M
    YATES, JRW
    [J]. NATURE GENETICS, 1994, 6 (02) : 193 - 196
  • [8] RAPID GENETIC-ANALYSIS OF FAMILIES WITH POLYCYSTIC KIDNEY DISEASE-1 BY MEANS OF A MICROSATELLITE MARKER
    HARRIS, PC
    THOMAS, S
    RATCLIFFE, PJ
    BREUNING, MH
    COTO, E
    LOPEZLARREA, C
    [J]. LANCET, 1991, 338 (8781) : 1484 - 1487
  • [9] A HIGH-RESOLUTION LINKAGE MAP OF HUMAN 9Q34.1
    HENSKE, EP
    OZELIUS, L
    GUSELLA, JF
    HAINES, JL
    KWIATKOWSKI, DJ
    [J]. GENOMICS, 1993, 17 (03) : 587 - 591
  • [10] DETECTION OF LOSS OF HETEROZYGOSITY AT THE HUMAN TP53 LOCUS USING A DINUCLEOTIDE REPEAT POLYMORPHISM
    JONES, MH
    NAKAMURA, Y
    [J]. GENES CHROMOSOMES & CANCER, 1992, 5 (01) : 89 - 90